Literature DB >> 3436342

Non-linear tissue binding of amikacin in rats: the effect of renal impairment.

I G Alonso1, J M Lanao, M C Saez, A A Dominguez-Gil, A Dominguez-Gil.   

Abstract

Amikacin levels in serum and tissues were determined in 115 Wistar rats, 70 with normal renal function (NRF) and the remaining 45 with terminal renal impairment (TRI). The results obtained in the animals with NRF show an accumulation of the antibiotic in all the tissues studied as compared with plasma levels, specially in the renal cortex and medulla. In the rats with TRI important alterations in the plasma and tissue kinetics of the antibiotics were observed. The plasma kinetics of amikacin in rats with TRI are characterised by significant alterations in the pharmacokinetic parameters, specially those defining the distribution processes of the antibiotic. In the tissues of the latter, a significant increase in the antibiotic concentration takes place, particularly in the renal cortex. The average half-lives of the antibiotic in the tissues of rats with TRI increase compared with the group of rats with NRF, though the difference are not so significant as in the case of the plasma half-life. The use of a specific kinetic distribution model, with linear and non-linear tissue binding, showed that significant variations occur in the partition coefficient and in the Michaelis-Menten parameters, which characterize the saturable binding of Amikacin to tissue in rats with NRF and TRI.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3436342     DOI: 10.1007/BF03189897

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  10 in total

1.  Distribution of gentamicin and amikacin in rabbit tissues.

Authors:  M L Kornguth; C M Kunin
Journal:  Antimicrob Agents Chemother       Date:  1977-06       Impact factor: 5.191

2.  Uranyl nitrate-induced acute renal failure in the rat: micropuncture and renal hemodynamic studies.

Authors:  W Flamenbaum; M L Huddleston; J S McNeil; R J Hamburger
Journal:  Kidney Int       Date:  1974-12       Impact factor: 10.612

3.  Properties of the Michaelis-Menten equation and its integrated form which are useful in pharmacokinetics.

Authors:  J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1973-04

4.  The pharmacokinetics of amikacin and gentamicin in volunteers: a comparison of individual differences.

Authors:  J M Walker; R Wise; M Mitchard
Journal:  J Antimicrob Chemother       Date:  1979-01       Impact factor: 5.790

5.  [Aminoglycoside tissue accumulation. A comparison between gentamycin and tobramycin in patients (author's transl)].

Authors:  J J Schentag
Journal:  Nouv Presse Med       Date:  1978-11-29

6.  [Accumulation and persistence of aminoglycosides in the renal parenchyma].

Authors:  M Rudhardt; P Blanchard; J Fabre
Journal:  Nouv Presse Med       Date:  1978-11-29

7.  [Comparative studies on the action of aminoglycosides and cephalosporins on the proximal tubule of the human kidney (author's transl)].

Authors:  A W Mondorf
Journal:  Nouv Presse Med       Date:  1978-11-29

8.  Gentamicin disposition and tissue accumulation on multiple dosing.

Authors:  J J Schentag; W J Jusko; J W Vance; T J Cumbo; E Abrutyn; M DeLattre; L M Gerbracht
Journal:  J Pharmacokinet Biopharm       Date:  1977-12

9.  Comparative distribution of gentamicin, tobramycin, sisomicin, netilmicin, and amikacin in interstitial fluid in rabbits.

Authors:  C Carbon; A Contrepois; S Lamotte-Barrillon
Journal:  Antimicrob Agents Chemother       Date:  1978-03       Impact factor: 5.191

10.  Behavior of amikacin in renal parenchyma of normal rats and of rats with acute obstructive renal insufficiency.

Authors:  M Rudhardt; J Fabre
Journal:  Nephron       Date:  1979       Impact factor: 2.847

  10 in total
  2 in total

1.  A physiologically based pharmacokinetic model for capreomycin.

Authors:  B Reisfeld; C P Metzler; M A Lyons; A N Mayeno; E J Brooks; M A Degroote
Journal:  Antimicrob Agents Chemother       Date:  2011-12-05       Impact factor: 5.191

2.  Initial In Vivo Evaluation of a Novel Amikacin-Deoxycholate Hydrophobic Salt Delivers New Insights on Amikacin Partition in Blood and Tissues.

Authors:  Styliani Xiroudaki; Federica Ianni; Samuele Sabbatini; Elena Roselletti; Claudia Monari; Roccaldo Sardella; Anna Vecchiarelli; Stefano Giovagnoli
Journal:  Pharmaceutics       Date:  2021-01-10       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.